Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This trial is conducted in Asia and Europe. The trial is planned to investigate the effectiveness and safety of NovoSeven® in patients with advanced cirrhosis and active variceal bleeding.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| activated recombinant human factor VII | Drug |
| Measure | Description | Time Frame |
|---|---|---|
| Treatment failure | Within 5 days after first trial product administration |
| Measure | Description | Time Frame |
|---|---|---|
| Mortality | ||
| Rebleeding | ||
| Control of acute bleeding |
Not provided
Inclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Global Clinical Registry (GCR, 1452) | Novo Nordisk A/S | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Novo Nordisk Investigational Site | Vienna | A 1090 | Austria | |||
| Novo Nordisk Investigational Site |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 18580208 | Result | Hsia CC, Chin-Yee IH, McAlister VC. Use of recombinant activated factor VII in patients without hemophilia: a meta-analysis of randomized control trials. Ann Surg. 2008 Jul;248(1):61-8. doi: 10.1097/SLA.0b013e318176c4ec. |
| Label | URL |
|---|---|
| Clinical Trials at Novo Nordisk | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
| Olomouc |
| 77520 |
| Czechia |
| Novo Nordisk Investigational Site | Prague | 12821 | Czechia |
| Novo Nordisk Investigational Site | Prague | 140 21 | Czechia |
| Novo Nordisk Investigational Site | Aarhus | 8000 | Denmark |
| Novo Nordisk Investigational Site | Helsinki | 00029 HUS | Finland |
| Novo Nordisk Investigational Site | Angers | 49033 | France |
| Novo Nordisk Investigational Site | Caen | 14033 | France |
| Novo Nordisk Investigational Site | Clichy | 92 188 | France |
| Novo Nordisk Investigational Site | Grenoble | 38043 | France |
| Novo Nordisk Investigational Site | Lille | 59037 | France |
| Novo Nordisk Investigational Site | Limoges | 87042 | France |
| Novo Nordisk Investigational Site | Marseille | 13385 | France |
| Novo Nordisk Investigational Site | Nantes | 44093 | France |
| Novo Nordisk Investigational Site | Nice | 06202 | France |
| Novo Nordisk Investigational Site | Paris | 75012 | France |
| Novo Nordisk Investigational Site | Paris | 75013 | France |
| Novo Nordisk Investigational Site | Toulouse | 31059 | France |
| Novo Nordisk Investigational Site | Villejuif | 94804 | France |
| Novo Nordisk Investigational Site | Berlin | 13353 | Germany |
| Novo Nordisk Investigational Site | Heidelberg | 69120 | Germany |
| Novo Nordisk Investigational Site | Leipzig | 04103 | Germany |
| Novo Nordisk Investigational Site | München | 81377 | Germany |
| Novo Nordisk Investigational Site | Münster | 48145 | Germany |
| Novo Nordisk Investigational Site | Ulm | 89081 | Germany |
| Novo Nordisk Investigational Site | Shatin | 32 | Hong Kong |
| Novo Nordisk Investigational Site | Milan | 20162 | Italy |
| Novo Nordisk Investigational Site | Naples | 80131 | Italy |
| Novo Nordisk Investigational Site | Palermo | 30146 | Italy |
| Novo Nordisk Investigational Site | Katowice | 40-752 | Poland |
| Novo Nordisk Investigational Site | Krakow | 31-826 | Poland |
| Novo Nordisk Investigational Site | Warsaw | 02-097 | Poland |
| Novo Nordisk Investigational Site | Badalona | 08916 | Spain |
| Novo Nordisk Investigational Site | Barcelona | 08003 | Spain |
| Novo Nordisk Investigational Site | Barcelona | 08025 | Spain |
| Novo Nordisk Investigational Site | Barcelona | 08036 | Spain |
| Novo Nordisk Investigational Site | Córdoba | 14004 | Spain |
| Novo Nordisk Investigational Site | Madrid | 28007 | Spain |
| Novo Nordisk Investigational Site | Madrid | 28034 | Spain |
| Novo Nordisk Investigational Site | Majadahonda | 28222 | Spain |
| Novo Nordisk Investigational Site | Taipei | 112 | Taiwan |
| Novo Nordisk Investigational Site | Leeds | LS9 7TF | United Kingdom |
| Novo Nordisk Investigational Site | London | WC1 6HX | United Kingdom |
| Novo Nordisk Investigational Site | Oxford | OX3 9DU | United Kingdom |
| ID | Term |
|---|---|
| D005355 | Fibrosis |
| ID | Term |
|---|---|
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided